THE DEAL, AT A GLANCE
From the announcementBiodesix
01Who is involvedBacked by VariousFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedBiodesix raised $70M Growth RoundFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersBiodesix is positioning AI blood protein diagnostics to reduce invasive lung cancer workups and extend its lung cancer testing portfolio.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Biodesix · Financing Record
Explore source-linked visual explanations for Biodesix. Unsupported claims are withheld while source review continues.
Record 874 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →